Skip to main content
TipRanks
Go Ultimate75% OFF

Versant Vantage I, L.P. Insider Profile

4 Followers

Versant Vantage I, L.P., Ten Percent Owner at Aprea Therapeutics, holds 231.21K shares in Repare Therapeutics (Ticker: RPTX), holds 216.67K shares in Aprea Therapeutics (Ticker: APRE).

Versant Vantage I, L.P.'s Trading History

RPTX
Repare Therapeutics
Jun 07, 2022―Uninformative Sell―$612.71K
APRE
Aprea Therapeutics
May 20, 2020Ten Percent OwnerUninformative Sell―$87.97K

You May Also Like

Versant Vantage I, L.P. insider profile FAQ

What is the percentage of profitable transactions made by Versant Vantage I, L.P.?
The percentage of profitable transactions made by Versant Vantage I, L.P. is 100%.
What is the average return per transaction made by Versant Vantage I, L.P.?
The average return per transaction made by Versant Vantage I, L.P. is 22.20%.
What stocks does Versant Vantage I, L.P. hold?
Versant Vantage I, L.P. holds: APRE, RPTX stocks.
What was Versant Vantage I, L.P.'s most profitable transaction?
Versant Vantage I, L.P.’s most profitable transaction was an Informative Buy of APRE stock on October 7, 2019. The return on the trade was 45.10%.
What is Versant Vantage I, L.P.'s role in Aprea Therapeutics?
Versant Vantage I, L.P.'s role in Aprea Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.